pyrroles has been researched along with Soft Tissue Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Algéo, MP; Bourdon, A; Chaire, V; Cousin, S; Italiano, A; Laroche-Clary, A; Le Loarer, F; Lucchesi, C; Rey, C; Savina, A; Shutzman, J; Toulmonde, M; Vélasco, V; Verbeke, S | 1 |
| Chabner, B; Richon, V | 1 |
| Anthony, SP; Bollag, G; Burton, EA; Chmielowski, B; Cohn, AL; Gee, C; Habets, G; Healey, JH; Hirth, P; Hsu, HH; Ibrahim, PN; Keedy, VL; Kim, MJ; Kwak, EL; Lin, PS; Marimuthu, A; Nguyen, H; Nolop, K; Peterfy, C; Puzanov, I; Ramanathan, RK; Sanftner, L; Severson, P; Shapiro, GI; Shellooe, R; Singh, AS; Staddon, AP; Tap, WD; Tong-Starksen, S; Tsang, G; van de Rijn, M; Visor, G; Von Hoff, DD; Wagner, AJ; Wainberg, ZA; Weiss, GJ; West, BL; Zhang, C; Zhang, J; Zhang, Y | 1 |
| Hirschberger, J; Holtermann, N; Kiupel, M | 1 |
| Akhurst, T; Bhuchar, G; Butrynski, JE; D'Adamo, DR; Demetri, GD; George, S; Harmon, DC; Keohan, ML; Maki, RG; Merriam, P; Morgan, J; O'Mara, MM; Schwartz, GK; Van den Abbeele, AD; Wagner, AJ; Yap, JT | 1 |
| Bovée, JV; Gelderblom, H; Hogendoorn, PC; Kroep, JR; van der Molen, AJ | 1 |
| Chandramouli, GV; Hyodo, F; Krishna, MC; Matsumoto, K; Matsumoto, S; Mitchell, JB; Munasinghe, JP | 1 |
| Casali, PG; Gronchi, A; Grosso, F; Morosi, C; Negri, T; Palassini, E; Pilotti, S; Stacchiotti, S | 1 |
| Deville, JL; Duffaud, F; Huynh, T; Salas, S | 1 |
| Benesch, M; Hanzer, M; Nebl, A; Pilhatsch, A; Spendel, S; Urban, C | 1 |
| Delank, S; Eich, H; Wendtner, CM | 1 |
| Lewis, VO; Ravi, V; Wang, WL | 1 |
| Blay, JY; de Balincourt, C; di Paola, ED; Duffaud, F; Fowst, C; Hogendoorn, PC; Judson, I; Le Cesne, A; Leahy, M; Ray-Coquard, I; van Glabbeke, M; Verweij, J | 1 |
4 review(s) available for pyrroles and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Extra-abdominal subcutaneous metastasis of a gastrointestinal stromal tumor: report of a case and a review of the literature.
Topics: Aged; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Bone Neoplasms; Carcinoma; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Indoles; Liver Neoplasms; Piperazines; Pyrimidines; Pyrroles; Soft Tissue Neoplasms; Subcutaneous Fat; Sunitinib | 2009 |
[Antiangionic drugs in soft tissue sarcoma].
Topics: Angiogenesis Inhibitors; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzenesulfonates; Bevacizumab; Doxorubicin; Humans; Indazoles; Indoles; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Pyridines; Pyrimidines; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Sarcoma; Soft Tissue Neoplasms; Sorafenib; Sulfonamides; Sunitinib; Vascular Endothelial Growth Factor A | 2010 |
[Multimodality therapy concepts for soft tissue sarcomas].
Topics: Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Combined Modality Therapy; Cross-Sectional Studies; Gastrointestinal Stromal Tumors; Humans; Hyperthermia, Induced; Imatinib Mesylate; Indoles; Neoadjuvant Therapy; Palliative Care; Piperazines; Prognosis; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Radiotherapy, Adjuvant; Sarcoma; Soft Tissue Neoplasms; Sunitinib | 2010 |
Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis.
Topics: Antineoplastic Agents; Benzamides; Giant Cell Tumors; Humans; Imatinib Mesylate; Indoles; Macrophage Colony-Stimulating Factor; Macrophages; Piperazines; Pyrimidines; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Soft Tissue Neoplasms; Sunitinib; Synovial Membrane; Synovitis, Pigmented Villonodular; Tendons | 2011 |
5 trial(s) available for pyrroles and Soft Tissue Neoplasms
| Article | Year |
|---|---|
CHK1 inhibition in soft-tissue sarcomas: biological and clinical implications.
Topics: Animals; Cell Line, Tumor; Checkpoint Kinase 1; Deoxycytidine; Dose-Response Relationship, Drug; Female; Gemcitabine; Genes, p53; Heterografts; Humans; Mice; Mice, Knockout; Mice, Nude; Mutation; Piperidines; Pyridines; Pyrroles; Soft Tissue Neoplasms; Tumor Suppressor Protein p53 | 2018 |
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.
Topics: Adult; Aged; Aminopyridines; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Discovery; Female; Giant Cell Tumors; Humans; Male; Middle Aged; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Soft Tissue Neoplasms; Tendons; Tumor Burden | 2015 |
The tyrosine kinase inhibitor toceranib in feline injection site sarcoma: efficacy and side effects.
Topics: Animals; Antineoplastic Agents; Cat Diseases; Cats; Female; Indoles; Injections; Male; Protein-Tyrosine Kinases; Pyrroles; Sarcoma; Soft Tissue Neoplasms | 2017 |
Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Female; Humans; Indoles; Male; Middle Aged; Positron-Emission Tomography; Pyrroles; Sarcoma; Soft Tissue Neoplasms; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2009 |
Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: a phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Topics: Adult; Aged; Antineoplastic Agents; Disease Progression; Female; Gastrointestinal Stromal Tumors; Guanidines; Humans; Infusions, Intravenous; Male; Middle Aged; Pyrroles; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome | 2007 |
4 other study(ies) available for pyrroles and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Structural Approaches to Cancer Drug Development.
Topics: Aminopyridines; Female; Giant Cell Tumors; Humans; Male; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Soft Tissue Neoplasms | 2015 |
Estimation of tumor microvessel density by MRI using a blood pool contrast agent.
Topics: Angiogenesis Inhibitors; Animals; Artifacts; Blood Volume; Carcinoma, Squamous Cell; Cerebrovascular Circulation; Contrast Media; Dextrans; Female; Ferrosoferric Oxide; Indoles; Injections, Intravenous; Magnetic Resonance Angiography; Magnetite Nanoparticles; Mice; Mice, Inbred C3H; Microvessels; Neovascularization, Pathologic; Phantoms, Imaging; Predictive Value of Tests; Pyrroles; Soft Tissue Neoplasms; Sunitinib | 2009 |
Tumor response to sunitinib malate observed in clear-cell sarcoma.
Topics: Antineoplastic Agents; Female; Humans; Indoles; Middle Aged; Pyrroles; Sarcoma, Clear Cell; Soft Tissue Neoplasms; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Necrosis of a skin autograft after short-term treatment with sunitinib in a 14-year-old girl with metastatic alveolar soft part sarcoma of the thigh.
Topics: Adolescent; Angiogenesis Inhibitors; Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Compassionate Use Trials; Female; Follow-Up Studies; Humans; Indoles; Lung Neoplasms; Necrosis; Postoperative Complications; Pyrroles; Radiotherapy, Adjuvant; Reoperation; Sarcoma, Alveolar Soft Part; Skin Transplantation; Soft Tissue Neoplasms; Sunitinib; Surgical Flaps; Thigh | 2010 |